1. Home
  2. BPMC vs WTS Comparison

BPMC vs WTS Comparison

Compare BPMC & WTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BPMC
  • WTS
  • Stock Information
  • Founded
  • BPMC 2008
  • WTS 1874
  • Country
  • BPMC United States
  • WTS United States
  • Employees
  • BPMC N/A
  • WTS N/A
  • Industry
  • BPMC Biotechnology: Pharmaceutical Preparations
  • WTS Metal Fabrications
  • Sector
  • BPMC Health Care
  • WTS Industrials
  • Exchange
  • BPMC Nasdaq
  • WTS Nasdaq
  • Market Cap
  • BPMC 5.8B
  • WTS 6.8B
  • IPO Year
  • BPMC 2015
  • WTS 1986
  • Fundamental
  • Price
  • BPMC $101.35
  • WTS $241.89
  • Analyst Decision
  • BPMC Buy
  • WTS Buy
  • Analyst Count
  • BPMC 18
  • WTS 5
  • Target Price
  • BPMC $125.88
  • WTS $222.00
  • AVG Volume (30 Days)
  • BPMC 789.4K
  • WTS 223.3K
  • Earning Date
  • BPMC 05-01-2025
  • WTS 05-07-2025
  • Dividend Yield
  • BPMC N/A
  • WTS 0.86%
  • EPS Growth
  • BPMC N/A
  • WTS 8.23
  • EPS
  • BPMC N/A
  • WTS 8.72
  • Revenue
  • BPMC $562,121,000.00
  • WTS $2,239,300,000.00
  • Revenue This Year
  • BPMC $44.49
  • WTS $2.34
  • Revenue Next Year
  • BPMC $33.04
  • WTS $3.60
  • P/E Ratio
  • BPMC N/A
  • WTS $27.75
  • Revenue Growth
  • BPMC 99.19
  • WTS 3.89
  • 52 Week Low
  • BPMC $73.04
  • WTS $175.37
  • 52 Week High
  • BPMC $121.90
  • WTS $248.17
  • Technical
  • Relative Strength Index (RSI)
  • BPMC 56.34
  • WTS 62.91
  • Support Level
  • BPMC $94.38
  • WTS $235.14
  • Resistance Level
  • BPMC $102.52
  • WTS $244.32
  • Average True Range (ATR)
  • BPMC 3.77
  • WTS 4.54
  • MACD
  • BPMC -0.38
  • WTS -0.74
  • Stochastic Oscillator
  • BPMC 79.29
  • WTS 51.80

About BPMC Blueprint Medicines Corporation

Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates includes AYVAKIT for the treatment of systemic mastocytosis, BLU-808 a potential treatment for mast cell disorders, including chronic urticaria, sleep disruption and other related diseases. It also has other drugs in its pipeline such as BLU-956, BLU-222 for treatment of breast cancer.

About WTS Watts Water Technologies Inc.

Watts Water Technologies Inc is a U.S.-based company that provides safety, energy efficiency, and water conservation products. Its product portfolio includes residential and commercial flow control products, which are sold for plumbing and hot water applications; HVAC and gas products, including commercial boilers, water heaters, heating solutions, etc.; drainage and water reuse products, including drainage products and engineered rainwater-harvesting solutions; and water quality products, including point-of-use and point-of-entry water filtration, conditioning, and scale prevention systems. Its products are marketed through brands like Watts, Apex, Bradley, Nexa, and others. Geographically, the company derives its key revenue from the Americas, followed by Europe and the APMEA region.

Share on Social Networks: